Valuation
- Market cap
- 1,122,000
- Revenue TTM
- $1,310,000
- Net income TTM
- $-1,300,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -99.24%
- Debt to equity
- 0.00
Trading
- Volume
- 1,347,800
- Avg volume
- 1,558,896
- Day's range
- $0.00 – $0.00
- Shares out
- 3,740,435,000
- Stochastic %K
- 100%
- Beta
- 1.68
- Analysts
- Strong Buy
- Price target
- —
Company profile
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a produ...
Show more
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.
- Industry
- Software - Infrastructure
- Sector
- Technology
- Phone
- 772 283 0020
- Website
- https://www.gelstat.com
- Address
- 3557 SW Corporate Parkway, Palm City, United States
Latest news
No headlines yet.
